Inflammatory tendencies and over production of IL-17 in the colon of young NOD mice are counteracted with diet change

  1. Arno Hänninen (arno.hanninen{at}
  1. 1Department of Medical Microbiology and Immunology, University of Turku, 20520 Turku, Finland
  2. 2Antimicrobial Research Laboratory, National Institute for Health and Welfare (THL), 20520 Turku, Finland


Objective Dietary factors influence diabetes development in the NOD mouse. Diet affects the composition of microbiota in the distal intestine, which may subsequently influence intestinal immune homeostasis. However, the specific effects of anti-diabetogenic diets on gut immunity and the explicit associations between intestinal immune disruption and type 1 diabetes onset remain unclear.

Research design and methods Gut microbiota of NOD mice fed a conventional diet or ProSobee formula were compared using gas chromatography. Colonic lamina propria immune cells were characterised in terms of activation markers, cytokine mRNA and Th17 and Foxp3+ T cell numbers using real time PCR and flow cytometry. Activation of diabetogenic CD4 T cells by purified B cells was assessed in both groups. Immune tolerance to autologous commensal bacteria was evaluated in vitro using thymidine-incorporation tests.

Results Young NOD mice showed a disturbed tolerance to autologous commensal bacteria. Increased numbers of activated CD4 T cells and (CD11b+CD11c+) dendritic cels and elevated levels of Th17 cells and IL23 mRNA were moreover observed in colon lamina propria. These phenomena were abolished when mice were fed an antidiabetogenic diet. The antidiabetogenic diet also altered the expression levels of costimulatory molecules and the capacity of peritoneal B cells to induce insulin-specific CD4 T cell proliferation.

Conclusions Young NOD mice show signs of subclinical colitis but the symptoms are alleviated by a diet change to an antidiabetogenic diet. Disrupted immune tolerance in the distal intestine may influence peritoneal cell pools and B-cell mediated activation of diabetogenic T cells.


    • Received January 29, 2010.
    • Accepted May 25, 2010.